Intratympanic treatment for tinnitus: A review

Noise and Health

Volumn 15, Issue 63, 2013, Pages 83-90

  Meyer, Thomas ^a  

^a Auris Medical AG   (Switzerland)

Author keywords

Cochlea; Hearing loss; Intratympanic injection; Round window; Tinnitus

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; LOCAL ANESTHETIC AGENT;

EARDRUM; HUMAN; INJECTION; METHODOLOGY; PATIENT ATTITUDE; REVIEW; TINNITUS; TREATMENT OUTCOME;

ANESTHETICS, LOCAL; CHOLINERGIC AGONISTS; GLUCOCORTICOIDS; HUMANS; INJECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; TINNITUS; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

MLCS; MLOWN;

EID: 84877284454     PISSN: 14631741     EISSN: 19984030     Source Type: Journal    
DOI: 10.4103/1463-1741.110285     Document Type: Review

References (60)

1. Lustig LR. The history of intratympanic drug therapy in otology. Otolaryngol Clin North Am 2004;37: 1001-17.
2. Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: A review. Microsc Res Tech 1997;36: 201-11.
3. Goycoolea MV. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol 2001;121: 437-47.
4. Nomura Y. Round window membrane. In: Pfaltz CR, editor. Otological Significance of the Round Window. Advances in Oto-Rhino-Laryngology. Vol. 33. Basel: S. Karger AG; 1984. p. 38-74.
5. Jahnke K. The blood-perilymph barrier. Arch Otorhinolaryngol 1980;228: 29-34.
6. Niedermeyer HP, Zahneisen G, Luppa P, Busch R, Arnold W. Cortisol levels in the human perilymph after intravenous administration of prednisolone. Audiol Neurootol 2003;8: 316-21.
7. Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007;28: 1124-30.
8. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117: 3-15.
9. Gouveris H, Schuler-Schmidt W, Mewes T, Mann W. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Otol Neurotol 2011;32: 756-60.
10. Topak M, Sahin-Yilmaz A, Ozdoganoglu T, Yilmaz HB, Ozbay M, Kulekci M. Intratympanic methylprednisolone injections for subjective tinnitus. J Laryngol Otol 2009;123: 1221-5.
11. Takahashi H, Sando I, Takagi A. Computer-aided three-dimensional reconstruction and measurement of the round window niche. Laryngoscope 1989;99: 505-9.
12. Salt AN, Plontke SK. Principles of local drug delivery to the inner ear. Audiol Neurootol 2009;14: 350-60.
13. Muehlmeier G, Biesinger E, Maier H. Safety of intratympanic injection of AM-101 in patients with acute inner ear tinnitus. Audiol Neurootol 2011;16: 388-97.
14. Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: A randomized trial. JAMA 2011;305: 2071-9.
15. Stepp CE, Voss SE. Acoustics of the human middle-ear air space. J Acoust Soc Am 2005;118: 861-71.
16. Trowbridge BC. Injection of the tympanum for chronic conductive deafness and associated tinnitus aurium: A preliminary report on the use of ethylmorphine hydrochloride. Arch Otolaryngol 1944;39: 523.
17. Trowbridge BC. Tympanosympathetic anesthesia for tinnitus aurium and secondary otalgia. Arch Otolaryngol 1949;50: 200-15.
18. Mitchell JF. Intratympanic injection for tinnitus aurium. J Laryngol Otol 1950;64: 576-9.
19. Bárány R. Die Beeinflussung des Ohrensausens durch iv injizierte Lokalanaesthetica. Acta Otolaryngol 1936: 23: 201-3.
20. Lewy RB. Treatment of tinnitus aurium by the iv use of local anesthetic agents. Arch Otolaryngol 1937;25: 178-83.
21. Coles RR, Thompson AC, O'Donoghue GM. Intra-tympanic injections in the treatment of tinnitus. Clin Otolaryngol Allied Sci 1992;17: 240-2.
22. Dodson KM, Sismanis A. Intratympanic perfusion for the treatment of tinnitus. Otolaryngol Clin North Am 2004;37: 991-1000.
23. Sakata E, Umeda Y. Treatment of tinnitus by transtympanic infusion of lidocaine. Auris Nasus Larynx 1976;3: 133-8.
24. Sakata H, Kojima Y, Koyama S, Furuya N, Sakata E. Treatment of cochlear tinnitus with transtympanic infusion of 4% lidocaine into the tympanic cavity. Int Tinnitus J 2001;7: 46-50.
25. Sakata E, Ito Y, Itoh A. Clinical experiences of steroid targeting therapy to inner ear for control of tinnitus. Int Tinnitus J 1997;3: 117-21.
26. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg 2007;133: 573-81.
27. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg 2007;133: 582-6.
28. Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: A prospective, randomized, double-blind, crossover trial. Am J Otol 1998;19: 196-201.
29. Araújo MF, Oliveira CA, Bahmad FM Jr. Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: Does it work? Arch Otolaryngol Head Neck Surg 2005;131: 113-7.
30. She W, Dai Y, Du X, Chen F, Ding X, Cui X. Treatment of subjective tinnitus: A comparative clinical study of intratympanic steroid injection versus oral carbamazepine. Med Sci Monit 2009;15:PI35-9.
31. Denk DM, Heinzl H, Franz P, Ehrenberger K. Caroverine in tinnitus treatment. A placebo-controlled blind study. Acta Otolaryngol 1997;117: 825-30.
32. Domeisen H, Hotz MA, Häusler R. Caroverine in tinnitus treatment. Acta Otolaryngol 1998;118: 606-8.
33. Ehrenberger K. Topical administration of Caroverine in somatic tinnitus treatment: Proof-of-concept study. Int Tinnitus J 2005;11: 34-7.
34. De Lucchi E. Transtympanic pilocarpine in tinnitus. Int Tinnitus J 2000;6: 37-40.
35. Alzamil KS, Linthicum FH Jr. Extraneous round window membranes and plugs: Possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol 2000;109: 30-2.
36. Penha R, Escada P. Round-window anatomical considerations in intratympanic drug therapy for inner-ear diseases. Int Tinnitus J 2005;11: 31-3.
37. Silverstein H, Rowan PT, Olds MJ, Rosenberg SI. Inner ear perfusion and the role of round window patency. Am J Otol 1997;18: 586-9.
38. Nomura Y. Round window niche and round window membrane. In: Pfaltz CR, editor. Otological Significance of the Round Window. Advances in Oto-Rhino-Laryngology. Vol. 33. Basel: S. Karger AG; 1984. p. 27-37.
39. Yoshioka M, Naganawa S, Sone M, Nakata S, Teranishi M, Nakashima T. Individual differences in the permeability of the round window: Evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol 2009;30: 645-8.
40. Plontke SK, Wood AW, Salt AN. Analysis of gentamicin kinetics in fluids of the inner ear with round window administration. Otol Neurotol 2002;23: 967-74.
41. Banerjee A, Parnes LS. The biology of intratympanic drug administration and pharmacodynamics of round window drug absorption. Otolaryngol Clin North Am 2004;37: 1035-51.
42. Bird PA, Murray DP, Zhang M, Begg EJ. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otol Neurotol 2011;32: 933-6.
43. Becvarovski Z, Bojrab DI, Michaelides EM, Kartush JM, Zappia JJ, La Rouere MJ. Round window gentamicin absorption: An in vivo human model. Laryngoscope 2002;112: 1610-3.
44. Plontke SK, Biegner T, Kammerer B, Delabar U, Salt AN. Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol 2008;29: 401-6.
45. Borkholder DA. State-of-the-art mechanisms of intracochlear drug delivery. Curr Opin Otolaryngol Head Neck Surg 2008;16: 472-7.
46. Borden RC, Saunders JE, Berryhill WE, Krempl GA, Thompson DM, Queimado L. Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane. Audiol Neurootol 2011;16: 1-11.
47. Iwai K, Nakagawa T, Endo T, Matsuoka Y, Kita T, Kim TS, et al. Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel. Laryngoscope 2006;116: 529-33.
48. Paulson DP, Abuzeid W, Jiang H, Oe T, O'Malley BW, Li D. A novel controlled local drug delivery system for inner ear disease. Laryngoscope 2008;118: 706-11.
49. Sheppard WM, Wanamaker HH, Pack A, Yamamoto S, Slepecky N. Direct round window application of gentamicin with varying delivery vehicles: A comparison of ototoxicity. Otolaryngol Head Neck Surg 2004;131: 890-6.
50. Sakamoto T, Nakagawa T, Horie RT, Hiraumi H, Yamamoto N, Kikkawa YS, et al. Inner ear drug delivery system from the clinical point of view. Acta Otolaryngol Suppl 2010;563: 101-4.
51. Salt AN, Hartsock J, Plontke S, Le Bel C, Piu F. Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation. Audiol Neurootol 2011;16: 323-35.
52. McCall AA, Swan EE, Borenstein JT, Sewell WF, Kujawa SG, McKenna MJ. Drug delivery for treatment of inner ear disease: Current state of knowledge. Ear Hear 2010;31: 156-65.
53. Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E, et al. Dexamethasone pharmacokinetics in the inner ear: Comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000;122: 521-8.
54. Mikulec AA, Hartsock JJ, Salt AN. Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures. Otol Neurotol 2008;29: 1020-6.
55. Qi W, Ding D, Salvi RJ. Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures. Hear Res 2008;236: 52-60.
56. Belhassen S, Saliba I. Pain assessment of the intratympanic injections: A prospective comparative study. Eur Arch Otorhinolaryngol 2012;269: 2467-73.
57. Nordang L, Linder B, Anniko M. Morphologic changes in round window membrane after topical hydrocortisone and dexamethasone treatment. Otol Neurotol 2003;24: 339-43.
58. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: Sudden hearing loss. Otolaryngol Head Neck Surg 2012;146:S1-35.
59. Duckert LG, Rees TS. Placebo effect in tinnitus management. Otolaryngol Head Neck Surg 1984;92: 697-9.
60. Langguth B, Salvi R, Elgoyhen AB. Emerging pharmacotherapy of tinnitus. Expert Opin Emerg Drugs 2009;14: 687-702.